CJC-1295 w/o DAC 10mg
CJC-1295 (Without DAC) – 10mg
Research Grade | Lyophilized Peptide
For Laboratory Research Use Only. Not for Human or Veterinary Use.
CJC-1295 (without DAC) is a synthetic growth hormone-releasing hormone (GHRH) analog peptide widely utilized in laboratory research involving endocrine signaling and growth hormone regulation pathways. The “without DAC” version refers to the non–Drug Affinity Complex form, resulting in a shorter half-life profile in experimental models compared to DAC-modified variants.
This product is supplied as a high-purity lyophilized peptide powder suitable for in-vitro and preclinical research applications.
Chemical Information
Peptide Name: CJC-1295 (without DAC)Synonym: Modified GRF (1-29)Peptide Class: GHRH analog
Peptide Length: 29 amino acids
Sequence (Modified GRF 1-29):Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: ~3367.9 g/mol
CAS Number: 863288-34-0 (reference form)
Purity: ≥99% (HPLC / MS verified)
Appearance: White to off-white lyophilized powder
Solubility: Soluble in sterile water and aqueous laboratory buffers
Fill Size: 10 mg per sterile vial
Mechanism & Research Context
CJC-1295 (without DAC) is a modified analog of human GHRH designed to:
Stimulate the pituitary GHRH receptor in research models
Induce pulsatile growth hormone release in experimental systems
Support in-vitro endocrine pathway investigations
The absence of the DAC (Drug Affinity Complex) results in a shorter active duration in laboratory studies compared to CJC-1295 DAC formulations.
Potential Research Applications
Growth hormone secretion studies
Pituitary receptor binding assays
Endocrine signaling pathway research
Cellular metabolism and anabolic pathway investigations
Preclinical hormone regulation models
